RxDoctor Payments Data

Heather Poblete

Adult Health · Hamilton, NJNPI 1730377102

Payments from drug & device makers

$900in general payments, 2019–2025

Across 42 payments — averaging $21.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$167
  • Lilly USA, LLC$121
  • Exact Sciences$105
  • Pfizer$98
  • Bayer$75
  • Boehringer Ingelheim$70
  • plus $264 from 11 others

What the payments were for

  • Food & beverage$900100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$900 in reported general payments places this provider in the 65th percentile of 1,135 adult health providers in New Jersey.

See all adult health providers in New Jersey

Medicare billing

Part B allowed, 2024
$14,628
Medicare patients
72
Services billed
168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide26$34,611
JanuviaSitagliptin Phosphate13$19,925
Janumet XrSitagliptin Phos/Metformin Hcl19$13,721
Bydureon BciseExenatide Microspheres13$10,445
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog14$6,077
Advair HfaFluticasone Propion/Salmeterol11$4,517
Albuterol Sulfate HfaAlbuterol Sulfate41$2,061
Amlodipine-ValsartanAmlodipine Besylate/Valsartan15$1,692
Rosuvastatin Calcium72$1,599
Repaglinide14$1,391
Levothyroxine Sodium90$1,178
Atorvastatin Calcium82$1,086
Labetalol Hcl15$1,028
Lubiprostone11$921
Metoprolol Succinate46$784

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$121$34,61126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,135 adult health providers in New Jersey.

Other adult health in Hamilton

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →